Methyl Prednisolone Injection 1000mg

Get a Price/Quote

MOQ : 5000 Packs, ,

Methyl Prednisolone Injection 1000mg Specification

Pacakaging (Quantity Per Box)
1 vial per box

Grade
Pharmaceutical Grade

Dosage Form
Injectable lyophilized powder

Usage
Parenteral use for severe inflammatory and autoimmune conditions

Salt Composition
Methylprednisolone sodium succinate

Storage
Store below 25C, protect from light and moisture

Dosage
1000mg

Expiration Date
24 months from manufacturing date

Medicine Type
Allopathic

Indication
Acute exacerbations of inflammatory disorders, multiple sclerosis, allergic reactions, severe asthma

Assay
Not less than 98%

CAS No
83-43-2

Molecular Formula
C22H30O5

Appearance
White to off-white lyophilized powder

Methyl Prednisolone Injection 1000mg Trade Information

Minimum Order Quantity
5000 Packs, ,

FOB Port
Mumbai

Payment Terms
Cash in Advance (CID), Cash Advance (CA)

Supply Ability
100000 Packs, , UNITS Per Month

Delivery Time
45 to 60 days Days

Sample Available
Yes

Sample Policy
Sample costs shipping and taxes has to be paid by the buyer

Packaging Details
AS PER BUYERS REQUIREMENT.

Main Export Market(s)
Eastern Europe, Western Europe, Middle East, Central America, Africa, Australia, South America, Asia, North America

Main Domestic Market
All India

Certifications
WHO GMP,ISO,FSSAI

About Methyl Prednisolone Injection 1000mg

Methyl Prednisolone Injection 1000mg delivers exceptional therapeutic efficacy for acute exacerbations of inflammatory disorders, severe asthma, and multiple sclerosis in adults. Available in an exclusive glass vial with rubber stopper, this celebrated allopathic medicine is formulated under GMP-certified conditions, ensuring dominant quality. Each vial contains 1000mg pharmaceutical-grade methylprednisolone sodium succinate, recommended for IV or IM administration and reconstituted with sterile water. For a limited time, take advantage of this highly rated solution, manufactured in India for export, dealership, and wholesale. Prescription required. Shelf life: 2 years.

Versatile Application & Dominant Advantage

Methyl Prednisolone Injection 1000mg is valued for its potent anti-inflammatory action, offering a key advantage in managing severe autoimmune and allergic reactions. Its excellent efficacy extends to critical care settings, hospitals, and clinics, and it is widely used by specialists in neurology and pulmonology. Besides acute flare-ups, this injectable finds celebrated utility in other autoimmune disorders, owing to its dominant pharmacological properties.

Supply Ability, Certificates & Payment Terms

This product is backed by substantial supply ability and GMP certification, promising a seamless handover for bulk procurement. Dealers and wholesalers can request detailed quotations reflecting competitive expenditure, and rest assured all Schedule H drug requirements are met. Flexible payment terms, export support, and regulatory compliance streamline the ordering process while ensuring quality from manufacturer to client.

FAQs of Methyl Prednisolone Injection 1000mg:

Q: How is Methyl Prednisolone Injection 1000mg administered?

A: It is intended for intravenous (IV) or intramuscular (IM) injection, with reconstitution using sterile water for injection as recommended.

Q: What conditions can benefit from this injection?

A: This medicine is dominant in treating acute exacerbations of inflammatory disorders, multiple sclerosis, severe asthma, and allergic reactions in adult patients.

Q: When should the vial be used after reconstitution?

A: Once reconstituted with sterile water for injection, the solution should be administered promptly and used according to medical guidance to maintain sterility and efficacy.

Q: Where is Methyl Prednisolone Injection 1000mg manufactured and registered?

A: It is manufactured in India under GMP standards and is registered for prescription-only use in India.

Q: What is the process for ordering and payment?

A: Dealers, exporters, and wholesalers may request a quotation, receive necessary certifications, and proceed with handover following agreed payment terms.